Iyer Radhakrishnan P. 4
4 · Spring Bank Pharmaceuticals, Inc. · Filed Jan 25, 2019
Insider Transaction Report
Form 4
Iyer Radhakrishnan P.
DirectorChief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-01-24+45,000→ 45,000 totalExercise: $10.35Exp: 2029-01-24→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 24, 2019, with 25% of the shares subject to the option vesting on January 24, 2020 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.